Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Vaping and Socioeconomic Inequalities in Smoking Cessation and Relapse: A Longitudinal Analysis of the UK Household Longitudinal Study

View ORCID ProfileIain Hardie, View ORCID ProfileMichael J. Green
doi: https://doi.org/10.1101/2022.08.30.22279385
Iain Hardie
1MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Iain Hardie
  • For correspondence: iain.hardie{at}glasgow.ac.uk
Michael J. Green
1MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J. Green
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Smoking is a key cause of socioeconomic health inequalities. Vaping is considered less harmful than smoking and has become a popular smoking cessation aid. However, there is currently limited evidence on the impact of vaping on inequalities in smoking.

Methods We used longitudinal data from 25,102 participants in waves 8-10 (2016-2020) of the UK Household Longitudinal Study to examine how vaping affects socioeconomic inequalities in smoking cessation and relapse. Marginal structural models were used to investigate whether vaping mediates or moderates associations between educational attainment and smoking cessation and relapse over time. Multiple Imputation and weights were used to adjust for missing data.

Results Respondents without degrees were less likely to stop smoking than those with a degree (OR: 0.65; 95% CI: 0.54-0.77), and more likely to relapse (OR: 1.67; 95% CI: 1.26-2.23) but regular vaping eliminated the inequality in smoking cessation (OR: 0.99; 95% CI: 0.54-1.82). Sensitivity analyses suggested that this finding did not hold when comparing those with or without any qualifications. Inequalities in smoking relapse did not differ by vaping status.

Conclusions Vaping may help reduce inequalities in smoking cessation between those with and without degree-level education and policy should favour vaping as a smoking cessation aid. Nevertheless, other supports or aids may be needed to reach the most disadvantaged (i.e. those with no qualifications) and to help people avoid relapse after cessation.

What is already known on this topic?

  • Socioeconomic inequalities in smoking cessation have narrowed in recent years since e-cigarettes have become more widely available as a cessation aid.

  • It is not clear whether this was as a result of increased vaping or other due to other confounding factors.

  • Existing research on vaping and socioeconomic inequalities in smoking cessation have been limited to using cross-sectional data.

What this study adds?

  • Using longitudinal data, over 2 years of follow-up, our study suggests that increased vaping among those of lower SEP (i.e. without degrees) is likely to have reduced socioeconomic inequalities in smoking cessation.

  • However, the positive impact of vaping on inequalities is focused around the upper to middle end of the educational distribution, and does not appear to help the most disadvantaged, or help with inequalities in smoking relapse.

How this study might affect research, practice or policy

  • Vaping can most likely have a net positive impact on inequalities in smoking. Policy should favour vaping, although other aids may be needed for the most disadvantaged and to help people avoid smoking relapse.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://osf.io/e3z8q

Funding Statement

This work was supported by the Medical Research Council (grant number: MC_UU_00022/2) and the Scottish Government Chief Scientist Office (grant number: SPHSU17).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The College of Medical, Veterinary and Life Sciences (MVLS) ethics committee waived ethical approval for this study. This is because the study used secondary data accessed via the UK Data Service, and the MVLS ethical committee stated that the UK Data Service have a suitable governance process that must be gone through before they release the data to researchers.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The dataset used for this analysis, the UK Household Longitudinal Study, aka Understanding Society, is an initiative funded by the Economic and Social Research Council and various Government Departments, with scientific leadership by the Institute for Social and Economic Research, University of Essex, and survey delivery by NatCen Social Research and Kantar Public. The research data are distributed by the UK Data Service (SN 6614).

https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=2000053#!/abstract

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted August 31, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Vaping and Socioeconomic Inequalities in Smoking Cessation and Relapse: A Longitudinal Analysis of the UK Household Longitudinal Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Vaping and Socioeconomic Inequalities in Smoking Cessation and Relapse: A Longitudinal Analysis of the UK Household Longitudinal Study
Iain Hardie, Michael J. Green
medRxiv 2022.08.30.22279385; doi: https://doi.org/10.1101/2022.08.30.22279385
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Vaping and Socioeconomic Inequalities in Smoking Cessation and Relapse: A Longitudinal Analysis of the UK Household Longitudinal Study
Iain Hardie, Michael J. Green
medRxiv 2022.08.30.22279385; doi: https://doi.org/10.1101/2022.08.30.22279385

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)